Paratek Pharmaceuticals
PRTK
#9029
Rank
โ‚ฌ0.10 B
Marketcap
1,90ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.69%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -โ‚ฌ41.89 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2022 the company made an earning of -โ‚ฌ38.68 Million a decrease over its 2021 earnings that were of -โ‚ฌ35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ41.89 Million8.3%
2022 -โ‚ฌ38.68 Million10.5%
2021 -โ‚ฌ35 Million-46.16%
2020 -โ‚ฌ65.01 Million-31.93%
2019 -โ‚ฌ95.5 Million11.12%
2018 -โ‚ฌ85.95 Million21.19%
2017 -โ‚ฌ70.92 Million-23.22%
2016 -โ‚ฌ92.37 Million54.68%
2015 -โ‚ฌ59.72 Million309.5%
2014 -โ‚ฌ14.59 Million-29.88%
2013 -โ‚ฌ20.8 Million
2011 -โ‚ฌ3.21 Million-59.18%
2010 -โ‚ฌ7.86 Million-53.53%
2009 -โ‚ฌ16.91 Million-161.93%
2008 โ‚ฌ27.3 M-187.43%
2007 -โ‚ฌ31.23 Million11.93%
2006 -โ‚ฌ27.9 Million31.69%
2005 -โ‚ฌ21.19 Million32.4%
2004 -โ‚ฌ16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ52.73 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.6 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.45 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA